U.S. markets open in 8 hours 42 minutes
  • S&P Futures

    3,827.50
    -21.00 (-0.55%)
     
  • Dow Futures

    30,711.00
    -157.00 (-0.51%)
     
  • Nasdaq Futures

    13,405.50
    -70.00 (-0.52%)
     
  • Russell 2000 Futures

    2,143.30
    -17.70 (-0.82%)
     
  • Crude Oil

    52.37
    -0.40 (-0.76%)
     
  • Gold

    1,855.90
    +0.70 (+0.04%)
     
  • Silver

    25.37
    -0.11 (-0.45%)
     
  • EUR/USD

    1.2136
    -0.0009 (-0.07%)
     
  • 10-Yr Bond

    1.0400
    -1.0400 (-100.00%)
     
  • Vix

    23.19
    -21.91 (-100.00%)
     
  • GBP/USD

    1.3648
    -0.0028 (-0.20%)
     
  • USD/JPY

    103.7430
    -0.0130 (-0.01%)
     
  • BTC-USD

    32,192.10
    -176.19 (-0.54%)
     
  • CMC Crypto 200

    650.77
    -26.13 (-3.86%)
     
  • FTSE 100

    6,638.85
    -56.22 (-0.84%)
     
  • Nikkei 225

    28,576.73
    -245.56 (-0.85%)
     

Weekly CFO Buys Highlight

GuruFocus.com

- By Myra Ramdenbourg

According to GuruFocus Insider Data, the recent CFO buys were: Blue Apron Holdings Inc. (APRN), RiceBran Technologies (RIBT) and Aeglea BioTherapeutics Inc. (AGLE).

Blue Apron Holdings Inc.: President, CEO, CFO and Treasurer Brad Dickerson bought 180,000 shares

President, CEO, CFO and Treasurer Brad Dickerson bought 180,000 shares for $3.93 per share on Dec. 13. The stock price has increased by 7.38%. Blue Apron Holdings Inc. has a market cap of $802.390 million and its shares were traded around $4.22. The company has a P/S ratio of 0.55.


SVP and Gen. Mgr. Consumer Products Timothy J Smith bought 25,000 shares for $3.89 per share on Dec. 11. The stock price has increased by 8.48%. Sr VP of Op and Fulfillment Pablo Cussatti sold 2,209 shares for $3.05 per share on Nov. 28. The stock price has increased by 38.36%. 10% Owner Round Capital IV Partner First sold 65,728 shares for $3.03 per share on Nov. 22. The stock price has increased by 39.27%.

RiceBran Technologies: CFO and EVP Brent Robert Rystrom bought 79,423 shares

CFO and EVP Brent Robert Rystrom bought 5,000 shares for $1.41 per share on Dec. 13. Since then, the stock price has increased by 3.55%. RiceBran Technologies has a market cap of $24.660 million and its shares were traded around $1.46. The company has a P/S ratio of 0.35.

RiceBran Technologies announced its 2017 second-quarter results with revenues of $3.45 million and gross profit of $1.14 million; the net income was $3.3 million. The 2016 total revenue was $39.41 million, a 1% decrease from the 2015 total revenue. The 2016 gross profit was $7.97 million, a 1% decrease from the 2015 gross profit. The 2016 net loss was $8.53 million.

CEO and President Robert D Smith bought 3,500 shares for $1.46 per share on Dec. 12. Since then, the stock price has not changed. President of USA Ingredients Michael Goose bought 2,500 shares for $1.44 per share on Dec. 14. Since then, the stock price has increased by 1.39%. Director Henk Hoogenkamp bought 6,000 shares for $1.46 per share on Dec. 12. Since then, the stock price has not changed.

Aeglea BioTherapeutics Inc.: CFO and VP Charles N York II bought 25,959 shares

CFO and VP Charles N York II bought 25,959 shares for $4.48 per share on Dec. 05. Since then, the stock price has increased by 8.71%. Aeglea Biotherapeutics Inc. has a market cap of $81.080 million and its shares were traded around $4.87. The company has a P/S ratio of 14.00.

Aeglea Biotherapeutics announced its 2017 third-quarter results with revenues and gross profit of $1.26 million; the net loss was $7.87 million. The 2016 total revenue and gross profit was $4.63 million, a 24% decrease from the 2015 total revenue. The 2016 net loss was $21.70 million.

Interim CEO Anthony G. Quinn bought 8,288 shares for $4.96 per share on Dec. 08. Since then, the stock price has decreased by 1.81%. Director Anthony G. Quinn bought 17,121 shares for $4.86 per share on Dec. 05. Since then, the stock price has increased by 0.21%.

Disclosure: none

This article first appeared on GuruFocus.